Search

Your search keyword '"Chaudhuri K"' showing total 3,550 results

Search Constraints

Start Over You searched for: Author "Chaudhuri K" Remove constraint Author: "Chaudhuri K"
3,550 results on '"Chaudhuri K"'

Search Results

5. Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

6. No evidence for an association of voxel-based morphometry with short-term non-motor outcomes in deep brain stimulation for Parkinson’s disease

9. Gastrointestinal barriers to levodopa transport and absorption in Parkinson's disease

11. A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson’s disease based in United Arab Emirates

12. List of contributors

15. Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

18. Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study

22. Detecting Parkinsonian Tremor from IMU Data Collected In-The-Wild using Deep Multiple-Instance Learning

25. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care

26. Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease

27. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

28. Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

32. Non-motor effects of deep brain stimulation in Parkinson's disease motor subtypes

41. Validation Study of the Parkinson's Disease Stigma Questionnaire (PDStigmaQuest).

42. Subthalamic Stimulation Improves Short-Term Satisfaction with Life and Treatment in Parkinson's Disease.

43. Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries

46. Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial

48. Gender gap in deep brain stimulation for Parkinson’s disease

Catalog

Books, media, physical & digital resources